$RSPI RespireRx Pharmaceuticals Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RespireRx Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in RespireRx Pharmaceuticals Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
RespireRx Pharmaceuticals Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALLNUTT ROBERT | Director | 65,500 | 255,450 | Aug 07 2012 | |||
| Benedik John F | Director | 30,000 | 117,000 | Aug 07 2012 | |||
| Carley David W. | Director | 1,899,158 | 7,406,716 | Aug 20 2012 | |||
| CASAMENTO CHARLES J | Director | 15,000 | 58,500 | Aug 07 2012 | |||
| COLEMAN JAMES H | Sr. VP, Business Development | 207,587 | 809,589 | Aug 24 2009 | |||
| COLEMAN JAMES H | Sr. VP, Business Development | 0 | 0 | Aug 14 2012 | |||
| COTMAN CARL W | Director | 74,500 | 290,550 | Aug 07 2012 | |||
| DRAKE PETER F | Director | 50,000 | 195,000 | Aug 07 2012 | |||
| JOHNSON M ROSS | Director | 30,000 | 117,000 | Aug 07 2012 | |||
| Johnson Steven Andrew | VP, Preclinical Development | 30,762 | 119,972 | Aug 24 2009 | |||
| Jones Timothy L. | CEO and President | 4,409,063 | 17,195,346 | Oct 02 2020 | |||
| Letendre Peter | Director | 684,031 | 2,667,721 | Aug 20 2012 | |||
| Lippa Arnold | Exec. Chairman & CSO | 4,500,598 | 17,552,332 | Oct 02 2020 | |||
| Lippa Arnold | Chairman, CEO and President | 15,000,000 | 58,500,000 | Apr 16 2014 | |||
| Lippa Arnold | Chairman, CEO and President | 0 | 0 | Jul 21 2014 | |||
| MacFarlane Katie | Director | 0 | 0 | Oct 02 2020 | |||
| MacFarlane Katie | Director | 2,000,000 | 7,800,000 | Sep 05 2014 | |||
| Mansbach Harry H | Chief Medical Officer | 107,000 | 417,300 | Dec 05 2005 | |||
| MANUSO JAMES S J | President and CEO | 74,252 | 289,583 | Dec 12 2017 | |||
| Margolis Jeff Eliot | SVP, CFO, Secret'y & Treasurer | 96,151,863 | 374,992,266 | Oct 02 2020 | |||
| Margolis Jeff Eliot | VP, Treasurer and Secretary | 15,000,000 | 58,500,000 | Jul 21 2014 | |||
| MESSINGER MARIA S | Chief Financial Officer | 49,064 | 191,350 | Aug 24 2009 | |||
| ORIGIN VENTURES II LP | 10% Owner | 24,200,507 | 94,381,977 | Sep 19 2012 | |||
| Purcell Richard David Jr. | SVP - Research and Development | 2,000,000 | 7,800,000 | Aug 04 2020 | |||
| Radin Marc M | Controller | 4,000,000 | 15,600,000 | Apr 16 2014 | |||
| ROGERS GARY ALLEN | Sr VP, Pharmaceutical Research | 127,700 | 498,030 | Dec 05 2005 | |||
| samyang optics co., ltd | 10% Owner | 10,134,483 | 39,524,484 | May 21 2012 | |||
| samyang optics co., ltd | 10% Owner | 10,166,033 | 39,647,529 | May 16 2012 | |||
| SAPIRSTEIN JAMES | Director | 0 | 0 | Dec 12 2017 | |||
| SAPIRSTEIN JAMES | Director | 2,000,000 | 7,800,000 | Sep 05 2014 | |||
| STOLL ROGER G PHD | Executive Chairman | 0 | 0 | Aug 14 2012 | |||
| STOLL ROGER G PHD | Executive Chairman | 100,000 | 390,000 | Aug 24 2009 | |||
| TOLLEFSON GARY D | Director | 28,000 | 109,200 | Feb 13 2008 | |||
| Tran Pierre V | Chief Medical Officer | 30,000 | 117,000 | Aug 24 2009 | |||
| Varney Mark A | President and CEO | 30,000 | 117,000 | Aug 24 2009 | |||
| WEINGARTEN ROBERT N | EVP & Chief Financial Officer | 0 | 0 | Jan 20 2017 | |||
| WEINGARTEN ROBERT N | Vice President and CFO | 15,000,000 | 58,500,000 | Jul 21 2014 |